Skip to main content
July 27, 2026 Media Coverage

Entera Bio Raises $275m for Phase III Osteoporosis Drug Trial

Capabilities
Corporate Capital Markets Life Sciences & Medical Technology
Offices
Tel Aviv^

Greenberg Traurig is mentioned in a Globes article titled "Entera Bio Raises $275m for Phase III Osteoporosis Drug Trial."

LINKS

Read "Entera Bio Raises $275m for Phase III Osteoporosis Drug Trial."

You May Also Be Interested In:
October 07, 2026 Press Release
Greenberg Traurig Advises Inseego on Acquisition of Nokia’s FWA Business 2 min read
October 06, 2026 Press Release
Greenberg Traurig Represents Opifex-Synergy in Acquisition of ECCO Equipment Less than a minute
October 05, 2026 Press Release
Greenberg Traurig Advises Founders of Peakside Capital on Acquisition by DWS 1 min read